Disruption of the dopamine D1/D2 heteromer using synthetic peptides

被引：0
|
作者：
Champion, Margaret [1 ]
Baraka, Adam [1 ]
Evans, Hedeel [1 ]
Heyl-Clegg, Deborah [1 ]
机构：
[1] Eastern Michigan Univ, Ypsilanti, MI 48197 USA
来源：
FASEB JOURNAL | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
610.5
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DOPAMINE D1/D2 RECEPTOR INTERACTION
    SASA, M
    AKAIKE, A
    OHNO, Y
    HARA, M
    TAKAORI, S
    [J]. JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1991, 45 (02): : 507 - 510
  • [2] Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation
    O'Dowd, Brian F.
    Ji, Xiaodong
    Nguyen, Tuan
    George, Susan R.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (01) : 23 - 28
  • [3] Maternal Separation Model of Postpartum Depression: Potential Role for Nucleus Accumbens Dopamine D1–D2 Receptor Heteromer
    Mateen Noori
    Ahmed Hasbi
    Meenalochani Sivasubramanian
    Marija Milenkovic
    Susan R. George
    [J]. Neurochemical Research, 2020, 45 : 2978 - 2990
  • [4] INTERACTION OF FLUNARIZINE WITH DOPAMINE D2 AND D1 RECEPTORS
    AMBROSIO, C
    STEFANINI, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 197 (2-3) : 221 - 223
  • [5] Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating
    Vinkers, Christiaan H.
    Risbrough, Victoria B.
    Geyer, Mark A.
    Caldwell, Sorana
    Low, Malcolm J.
    Hauger, Richard L.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2007, 86 (03) : 550 - 558
  • [6] Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys:: Antiamphetamine effects and extrapyramidal side effects
    Peacock, L
    Hansen, L
    Morkeberg, F
    Gerlach, J
    [J]. NEUROPSYCHOPHARMACOLOGY, 1999, 20 (01) : 35 - 43
  • [7] Chronic Dopamine D1, Dopamine D2 and Combined Dopamine D1 and D2 Antagonist Treatment in Cebus Apella Monkeys: Antiamphetamine Effects and Extrapyramidal Side Effects
    L Peacock
    L Hansen
    F Mørkeberg
    J Gerlach
    [J]. Neuropsychopharmacology, 1999, 20 : 35 - 43
  • [8] Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors
    Dall'Olio, R
    Gaggi, R
    Voltattorni, M
    Tanda, A
    Gandolf, O
    [J]. BEHAVIOURAL PHARMACOLOGY, 2002, 13 (08): : 633 - 638
  • [9] Evidence against dopamine D1/D2 receptor heteromers
    Frederick, A. L.
    Yano, H.
    Trifilieff, P.
    Vishwasrao, H. D.
    Biezonski, D.
    Meszaros, J.
    Urizar, E.
    Sibley, D. R.
    Kellendonk, C.
    Sonntag, K. C.
    Graham, D. L.
    Colbran, R. J.
    Stanwood, G. D.
    Javitch, J. A.
    [J]. MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1373 - 1385
  • [10] Dopamine D1–D2 receptor heterodimers: A literature review
    Vekshina N.L.
    Anokhin P.K.
    Veretinskaya A.G.
    Shamakina I.Y.
    [J]. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2017, 11 (2) : 111 - 119
12345